VANCOUVER, Aug. 26 /PRNewswire-FirstCall/ - QLT Inc. announced today that QLT USA, Inc., its wholly-owned subsidiary, has entered into an exclusive license agreement ...
LONDON (MarketWatch) -- Reckitt Benckiser Pharmaceuticals on Tuesday said it has signed an exclusive licensing agreement with QLT, Inc. subsidiary QLT USA for its Atrigel sustained-release drug ...
VANCOUVER–QLT Inc. will get up to US$30 million from an agreement to license its Atrigel sustained-release drug delivery technology to Reckitt Benckiser Pharmaceuticals. It’s the latest divestiture ...
26th August 2008Reckitt Benckiser Pharmaceuticals Inc. Announces Exclusive Licensing Agreement with QLT USA, Inc. for Atrigel‚® Technology -Technology allows injection of pharmaceuticals for long-term ...
26th August 2008Reckitt Benckiser Pharmaceuticals Inc. Announces Exclusive Licensing Agreement with QLT USA, Inc. for Atrigel‚® Technology -Technology allows injection of pharmaceuticals for long-term ...
VANCOUVER , Oct. 1 /CNW/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the sale of all of the shares of its wholly-owned U.S. subsidiary, QLT USA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results